123 related articles for article (PubMed ID: 8341501)
1. Immunocytologic findings in a case of Vogt-Koyanagi-Harada syndrome.
Kahn M; Pepose JS; Green WR; Miller J; Foos RY
Ophthalmology; 1993 Aug; 100(8):1191-8. PubMed ID: 8341501
[TBL] [Abstract][Full Text] [Related]
2. Immunopathologic study of Vogt-Koyanagi-Harada syndrome.
Chan CC; Palestine AG; Kuwabara T; Nussenblatt RB
Am J Ophthalmol; 1988 Jun; 105(6):607-11. PubMed ID: 3259837
[TBL] [Abstract][Full Text] [Related]
3. Vitiligo in Vogt-Koyanagi-Harada disease: immunohistological analysis of inflammatory site.
Okada T; Sakamoto T; Ishibashi T; Inomata H
Graefes Arch Clin Exp Ophthalmol; 1996 Jun; 234(6):359-63. PubMed ID: 8738701
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical studies of Vogt-Koyanagi-Harada disease with sunset sky fundus.
Inomata H; Sakamoto T
Curr Eye Res; 1990; 9 Suppl():35-40. PubMed ID: 1974489
[TBL] [Abstract][Full Text] [Related]
5. Major histocompatibility complex and strong human leukocyte antigen-DRB1 and gender association with Vogt-Koyanagi-Harada syndrome in Mexican Mestizos.
Aláez C; Flores-A H; Concha del Río LE; Munguía A; Rodríguez A; García D; Arellanes L; Gorodezky C
Hum Immunol; 2011 Dec; 72(12):1198-203. PubMed ID: 21964432
[TBL] [Abstract][Full Text] [Related]
6. Class II major histocompatibility complex on melanocytes of Vogt-Koyanagi-Harada disease.
Sakamoto T; Murata T; Inomata H
Arch Ophthalmol; 1991 Sep; 109(9):1270-4. PubMed ID: 1929956
[TBL] [Abstract][Full Text] [Related]
7. Absence of recognition of common melanocytic antigens by T cells isolated from the cerebrospinal fluid of a Vogt-Koyanagi-Harada patient.
Abad S; Wieërs G; Colau D; Wildmann C; Delair E; Dhote R; Brézin AP; Kawakami Y; Coulie PG; van der Bruggen P
Mol Vis; 2014; 20():956-69. PubMed ID: 24991188
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and immunohistochemistry correlation in a case of Vogt-Koyanagi-Harada disease.
Das D; Boddepalli A; Biswas J
Indian J Ophthalmol; 2019 Jul; 67(7):1217-1219. PubMed ID: 31238472
[TBL] [Abstract][Full Text] [Related]
9. HLA class II genes in Vogt-Koyanagi-Harada disease.
Islam SM; Numaga J; Fujino Y; Hirata R; Matsuki K; Maeda H; Masuda K
Invest Ophthalmol Vis Sci; 1994 Oct; 35(11):3890-6. PubMed ID: 7928186
[TBL] [Abstract][Full Text] [Related]
10. Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens.
Sugita S; Takase H; Taguchi C; Imai Y; Kamoi K; Kawaguchi T; Sugamoto Y; Futagami Y; Itoh K; Mochizuki M
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2547-54. PubMed ID: 16723469
[TBL] [Abstract][Full Text] [Related]
11. [The association of HLA-DR4 gene subtypes with Vogt-Koyanagi-Harada syndrome].
Xiao T; Jiang Y; You X
Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):268-71. PubMed ID: 10451958
[TBL] [Abstract][Full Text] [Related]
12. [Ocular infiltrating CD 4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens].
Sugita S
Nippon Ganka Gakkai Zasshi; 2008 Nov; 112(11):953-64. PubMed ID: 19069378
[TBL] [Abstract][Full Text] [Related]
13. Humoral immune response directed against LEDGF in patients with VKH.
Yamada K; Senju S; Shinohara T; Nakatsura T; Murata Y; Ishihara M; Nakamura S; Ohno S; Negi A; Nishimura Y
Immunol Lett; 2001 Oct; 78(3):161-8. PubMed ID: 11578690
[TBL] [Abstract][Full Text] [Related]
14. T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis.
Damico FM; Cunha-Neto E; Goldberg AC; Iwai LK; Marin ML; Hammer J; Kalil J; Yamamoto JH
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2465-71. PubMed ID: 15980237
[TBL] [Abstract][Full Text] [Related]
15. Profiling human leukocyte antigens in Vogt-Koyanagi-Harada syndrome.
Zhang XY; Wang XM; Hu TS
Am J Ophthalmol; 1992 May; 113(5):567-72. PubMed ID: 1575232
[TBL] [Abstract][Full Text] [Related]
16. Vogt-Koyanagi-Harada syndrome in patients of Vietnamese ancestry.
Riddington L; Hall AJ; Tait B; Nicholson I; Varney M
Aust N Z J Ophthalmol; 1996 May; 24(2):147-9. PubMed ID: 9199747
[TBL] [Abstract][Full Text] [Related]
17. Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt-Koyanagi-Harada disease.
Norose K; Yano A; Wang XC; Tokushima T; Umihira J; Seki A; Nohara M; Segawa K
Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):33-9. PubMed ID: 8300361
[TBL] [Abstract][Full Text] [Related]
18. Association of HLA antigens with Vogt-Koyanagi-Harada syndrome in a Han Chinese population.
Zhao M; Jiang Y; Abrahams IW
Arch Ophthalmol; 1991 Mar; 109(3):368-70. PubMed ID: 2003797
[TBL] [Abstract][Full Text] [Related]
19. Frequent immune response to a melanocyte specific protein KU-MEL-1 in patients with Vogt-Koyanagi-Harada disease.
Otani S; Sakurai T; Yamamoto K; Fujita T; Matsuzaki Y; Goto Y; Ando Y; Suzuki S; Usui M; Takeuchi M; Kawakami Y
Br J Ophthalmol; 2006 Jun; 90(6):773-7. PubMed ID: 16481377
[TBL] [Abstract][Full Text] [Related]
20. Association between Vogt-Koyanagi-Harada syndrome and HLA-DR1 and -DR4 in Hispanic patients living in southern California.
Weisz JM; Holland GN; Roer LN; Park MS; Yuge AJ; Moorthy RS; Forster DJ; Rao NA; Terasaki PI
Ophthalmology; 1995 Jul; 102(7):1012-5. PubMed ID: 9121744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]